Geron and AngioChem in brain cancer pact
This article was originally published in Scrip
Executive Summary
Geron has expanded its clinical oncology pipeline through a worldwide exclusive licensing pact with AngioChem aimed at getting anticancer treatments across the blood brain barrier.